In the News
The U’s Center for Magnetic Resonance Research keeps inventing better ways to diagnose, treat, and monitor disease
Open-water swimmer traverses the globe, raising money for breast cancer research at the Masonic Cancer Center
Six weeks before she was set to swim across the English Channel for the first time, Michelle Macy learned that her mother, Kathleen, had been diagnosed with breast cancer.
Branden Moriarity harnesses the power of genome engineering, where scientists reprogram DNA, to develop innovative immunotherapy approaches for treating highly lethal forms of cancer. Moriarity’s work, combined with that of his colleagues, was the foundation for B-MoGen Biotechnologies Inc., a University startup company launched in 2016. He currently serves as B-MoGen’s chief scientific officer. Moriarity, a Masonic Cancer Center researcher, was a winner of the 2019 Early Innovator Award.
Doctors at the University of Minnesota are the first in the country to use a breakthrough brain cancer treatment.
Author: Kent Erdahl
Published: 11:13 PM CST February 14, 2019
Updated: 11:16 PM CST February 14, 2019
Large animal models can be important translational steps between basic research in rodents and clinical care in humans. Ever thought about a pig?
Featuring Christopher Moertel, MD.